FangJie Liu

Sun Yat-sen University — China

Medicine · Health Sciences

9h-index326citations61works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(38), Lung Cancer Treatments and Mutations(26), Lung Cancer Research Studies(21), Medical Imaging Techniques and Applications(11), Advanced Radiotherapy Techniques(10)

Publications61 total

Magnetic resonance‐guided split‐course hypo‐fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non–small cell lung cancer: A single arm, phase 2 study
Cancer·2025Open Access
Abbreviated dynamic total-body [18F]FDG PET/CT protocols for predicting response in locally advanced non-small cell lung cancer via Patlak-Ki analysis
Quantitative Imaging in Medicine and Surgery·2025Open Access
Real-world disproportionality analysis of cardiac failure associated with novel antineoplastic agents in breast cancer: a pharmacovigilance study
Frontiers in Immunology·2025· 1 citedOpen Access
Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial
Signal Transduction and Targeted Therapy·2025· 2 citedOpen Access
Stability of gut microbiota in non-small cell lung cancer patients during chemoradiotherapy and its association with radiation pneumonitis
iScience·2025Open Access
Early Nutritional Intervention in Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study
Nutrients·2025· 2 citedOpen Access
Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trial
EClinicalMedicine·2025· 2 citedOpen Access
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial
EClinicalMedicine·2025· 5 citedOpen Access
Treatment Outcomes of Zanubrutinib-Based Regimen in Newly Diagnosed Patients with MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Real-World Study
Blood·2024
Repeated dynamic [18F]FDG PET/CT imaging using a high-sensitivity PET/CT scanner for assessing non-small cell lung cancer patients undergoing induction immuno-chemotherapy followed by hypo-fractionated chemoradiotherapy and consolidative immunotherapy: report from a prospective observational study (GASTO-1067)
European Journal of Nuclear Medicine and Molecular Imaging·2024· 6 cited
Supplementary Table S2 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S6 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S1 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S1 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S4 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S2 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S5 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S3 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S3 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
Supplementary Table S4 from Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non–Small Cell Lung Cancer: A Phase I Study
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Bo Qiu(43), Hui Liu(33), JinYu Guo(24), Daquan Wang(23), ShiYang Zheng(17), DaQuan Wang(17), PengXin Zhang(17), Li Chen(16), NaiBin Chen(16), YingYi Zou(14), JinYu Guo(13), Qiwen Li(11), Suping Guo(11), Yingjia Wu(11), Rui Zhou(11), Yuming Rong(11), HongMei Zhang(10), YiMei Liu(10), Chu Chu(8), Rui Zhou(8)